Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05162391 · ClinicalTrials.gov registry record · NA
Inflammation in Methamphetamine and STIs (IMSTI)
A NA study of Methamphetamine-dependence and Rectal Gonorrhea, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05162391 is a NA study of Methamphetamine-dependence and Rectal Gonorrhea that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 105-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05162391, a NA study of Methamphetamine-dependence and Rectal Gonorrhea, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial aims to investigate the effects of a decline in methamphetamine use on rectal inflammatory cytokine levels, substance use contexts, and HIV/STI risk behavior. This clinical trial also seeks to evaluate joint effects of methamphetamine use and rectal gonorrhea/chlamydia infection on rectal inflammatory cytokine levels. The proposed trial will consist of 40 MSM, half with rectal gonorrhea/chlamydia infection at enrollment (n=20), with methamphetamine use disorder that will receive contingency management for methamphetamine reduction. Following baseline measurement, participants will be observed over the course of 8 weeks, where participants will complete behavioral surveys, provide urine for drug testing, and rectal samples for measurement of rectal inflammatory cytokine levels.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (1)
California
- UCLA Vine Street Clinic - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05162391
The ClinicalTrials.gov registry entry for NCT05162391 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 105-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (71% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Methamphetamine-dependence appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT05162391 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05162391 about?
NCT05162391 is a clinical study titled "Inflammation in Methamphetamine and STIs (IMSTI)". This clinical trial aims to investigate the effects of a decline in methamphetamine use on rectal inflammatory cytokine levels, substance use contexts, and HIV/STI risk behavior. This clinical trial also seeks to evaluate joint effects of methamphetamine use and rectal gonorrhea/chlamydia infection ...
What is the current status of trial NCT05162391?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-31. Estimated completion is 2027-06-30.
What conditions does trial NCT05162391 study?
This clinical trial studies the following conditions: Methamphetamine-dependence, Rectal Gonorrhea, Rectal Chlamydia.
What interventions are being tested in trial NCT05162391?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05162391?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05162391 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine-dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
-
MHealth Incentivized Adherence Plus Patient Navigation
ACTIVE NOT RECRUITING · NA
-
The Human Stress Response in a Simulated ED Setting
ACTIVE NOT RECRUITING · NA
-
Pilot TMS for Methamphetamine Use Disorder
COMPLETED · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.